CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | French Glendon E. III President and CEO | Sale | −1,032 | $11.49 | $12K | 1,205,048 |
| 2023-06-01 | French Glendon E. III President and CEO | Sale | −1,577 | $11.48 | $18K | 1,203,471 |
| 2023-06-01 | French Glendon E. III President and CEO | Sale | −3,924 | $11.48 | $45K | 1,199,547 |
| 2023-06-01 | Florin Daniel P Director | Grant or award | +12,620 | 25,752 | ||
| 2023-06-01 | Ferrari Richard Director | Grant or award | +12,620 | 42,655 | ||
| 2023-06-01 | Burns Thomas William Director | Grant or award | +12,620 | 21,030 | ||
| 2023-06-01 | Mead Dana G Jr. Director | Grant or award | +12,620 | 47,345 | ||
| 2023-03-01 | Sung Derrick Chief Financial Officer | Sale | −458 | $11.03 | $5K | 262,288 |
| 2023-03-01 | Sung Derrick Chief Financial Officer | Sale | −806 | $11.03 | $9K | 261,482 |
| 2023-03-01 | Sung Derrick Chief Financial Officer | Grant or award | +138,000 | 399,482 | ||
| 2023-03-01 | Sung Derrick Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +94,500 | 94,500 | ||
| 2023-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −437 | $11.03 | $5K | 181,762 |
| 2023-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −769 | $11.03 | $8K | 180,993 |
| 2023-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Grant or award | +78,900 | 259,893 | ||
| 2023-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +54,000 | 54,000 | ||
| 2023-03-01 | Lehman David Aaron General Counsel | Sale | −458 | $11.03 | $5K | 43,702 |
| 2023-03-01 | Lehman David Aaron General Counsel | Sale | −806 | $11.03 | $9K | 42,896 |
| 2023-03-01 | Lehman David Aaron General Counsel | Grant or award | +118,300 | 161,196 | ||
| 2023-03-01 | Lehman David Aaron General Counsel | Grant or award · Employee Stock Option (right to buy) | +81,000 | 81,000 | ||
| 2023-03-01 | French Glendon E. III President and CEO | Sale | −1,184 | $11.03 | $13K | 1,034,291 |
Page 13 of 23 · 450 trades